SHELBY RUBENSTEIN: Open Payments
NPI 1912503715 · EXTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 23 payments from 14 companies in 2025. Trend: 2023 $324 · 2024 $610 · 2025 $496
Food & beverage: $383Education: $113
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $181 |
| Organon LLC | 5 | $50 |
| Galderma Laboratories, L.P. | 2 | $39 |
| Almirall LLC | 1 | $32 |
| Incyte Corporation | 1 | $29 |
| UCB, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
| LEO Pharma Inc. | 1 | $18 |
Products named: TREMFYA, NEMLUVIO, Klisyri, OPZELURA, VTAMA, Bimzelx, CIBINQO, TALTZ.
Industry payments across PA — which companies pay providers there.
